Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #1350008

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
52,103,000 DKK
10,161,000 DKK
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
63,950,000 DKK
31,904,000 DKK
Payments for share issue costs
71,908,000 DKK
47,354,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.